U.S. flag An official website of the United States government
  1. Home
  2. About FDA
  3. FDA Organization
  4. Office of the Commissioner
  5. Office of the Chief Scientist
  6. National Center for Toxicological Research
  7. Science & Research (NCTR)
  8. NCTR Publications
  9. NCTR COVID-19/SARS-CoV-2 Publications
  1. NCTR Publications

NCTR COVID-19/SARS-CoV-2 Publications

*As of 3/18/2024

Date Title Journal DOI
November 2023 Developing SARS-CoV-2 Main Protease Binding Prediction Random Forest Model for Drug Repurposing for COVID-19 Treatment Experimental Biology and Medicine 10.1177/15353702231209413
October 2023 Analyzing 3D Structures of the SARS-CoV-2 Main Protease Reveals Structural Features of Ligand Binding for COVID-19 Drug Discovery Drug Discovery Today 10.1016/j.drudis.2023.103727
June 2023 Evaluation of Association of Anti-PEG Antibodies with Anaphylaxis after mRNA COVID-19 Vaccination Vaccine 10.1016/j.vaccine.2023.05.029
February 2023 Distinct Conformations of SARS-CoV-2 Omicron Spike Protein and its Interaction with ACE2 and Antibody International Journal of Molecular Sciences 10.3390/ ijms24043774
December 2022 Enhanced Virulence and Waning Vaccine-Elicited Antibodies Account for SARS-CoV-2 Delta and Kappa Breakthrough Infections in K18-hACE2 Passive Transfer Model iScience 10.1016/j.isci.2022.105507
November 2022 Temporal Dynamics of SARS-CoV-2 Genome and Detection of Variants of Concern in Wastewater Influent from Two Metropolitan Areas in Arkansas Science of the Total Environment 10.1016/j.scitotenv.2022.157546
October 2022 Applying Imaging Mass Spectrometry to Define the N-glycan Profiles of Co-localized Virus and Immune Cell Infiltrates in Post-COVID-19 Infected Lung Autopsy Tissues Frontiers in Analytical Science 10.3389/frans.2022.1021008
August 2022 Evaluation of the Mutagenic Effects of Molnupiravir and N4-hydroxycytidine in Bacterial and Mammalian Cell by HiFi Sequencing Environmental and Molecular Mutagenesis 10.1002/em.22510
August 2022 NeuroCORD: A Language Model to Facilitate COVID-19-Associated Neurological Disorder Studies International Journal of Environmental Research and Public Health 10.1002/em.22510
February 2022 AI-Powered Drug Repurposing for Developing COVID-19 Treatments Reference Module in Biomedical Sciences 10.1016/B978-0-12-824010-6.00005-8
November 2021 AI-Based Language Models Powering Drug Discovery and Development Drug Discovery Today 10.1016/j.drudis.2021.06.009
July 2021 Biochemical Features and Mutations of Key Proteins in SARS-CoV-2 and Their Impacts on RNA Therapeutics Biochemical Pharmacology 10.1016/j.bcp.2021.114424
July 2021 Can SARS-CoV-2 Infect the Central Nervous System via the Olfactory Bulb or the Blood-Brain Barrier? Brain, Behavior, and Immunity 10.1016/j.bbi.2020.12.031
July 2021 Informing Selection of Drugs for COVID-19 Treatment Through Adverse Events Analysis Scientific Reports 10.1038/s41598-021-93500-5
May 2021 Identification of Epidemiological Traits by Analysis of SARS-CoV-2 Sequences Viruses 10.3390/v13050764
March 2021 Conformational Changes of the Receptor Binding Domain of SARS-CoV-2 Spike Protein and Prediction of a B-Cell Antigenic Epitope Using Structural Data Frontiers in Artificial Intelligence 10.3389/frai.2021.630955
January 2021 Elucidating Interactions Between SARS-CoV-2 Trimeric Spike Protein and ACE2 Using Homology Modeling and Molecular Dynamics Simulations Frontiers in Chemistry 10.3389/fchem.2020.622632
December 2020 Pericytes Within a Pulmonary Neurovascular Unit in COVID-19-elicited Pathologic Changes Current Neurovascular Research 10.2174/1567202617666201222112639
December 2020 FDALabel for Drug Repurposing Studies and Beyond Nature Biotechnology 10.1038/s41587-020-00751-0



Back to Top